| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.5 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |